Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
KERX [NASD]
Keryx Biopharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.00 Insider Own2.10% Shs Outstand91.94M Perf Week2.00%
Market Cap1.36B Forward P/E- EPS next Y-0.88 Insider Trans-9.89% Shs Float90.20M Perf Month-2.44%
Income-88.90M PEG- EPS next Q-0.37 Inst Own84.10% Short Float25.21% Perf Quarter13.86%
Sales10.30M P/S132.02 EPS this Y-65.70% Inst Trans10.82% Short Ratio14.53 Perf Half Y-0.67%
Book/sh1.07 P/B13.82 EPS next Y24.10% ROA-72.40% Target Price25.17 Perf Year10.70%
Cash/sh1.29 P/C11.50 EPS next 5Y30.00% ROE-86.20% 52W Range11.53 - 18.48 Perf YTD14.21%
Dividend- P/FCF- EPS past 5Y13.20% ROI-103.70% 52W High-19.97% Beta3.10
Dividend %- Quick Ratio4.30 Sales past 5Y42.30% Gross Margin98.10% 52W Low28.27% ATR0.72
Employees92 Current Ratio4.30 Sales Q/Q- Oper. Margin- RSI (14)46.16 Volatility5.68% 4.46%
OptionableYes Debt/Eq0.00 EPS Q/Q-100.00% Profit Margin- Rel Volume1.04 Prev Close14.67
ShortableYes LT Debt/Eq0.00 EarningsNov 06 BMO Payout- Avg Volume1.56M Price14.79
Recom1.70 SMA20-3.09% SMA50-5.60% SMA200-1.78% Volume1,631,944 Change0.82%
Dec-02-14Reiterated FBR Capital Underperform
Nov-28-14Reiterated Maxim Group Buy $26 → $32
Nov-17-14Reiterated FBR Capital Underperform $14 → $12
Sep-22-14Resumed Oppenheimer Outperform $22
Sep-08-14Downgrade FBR Capital Mkt Perform → Underperform
Aug-14-14Initiated FBR Capital Mkt Perform $16
May-23-14Reiterated H.C. Wainwright Buy $19
May-12-14Reiterated MLV & Co Buy $27 → $21
Apr-04-14Reiterated Ladenburg Thalmann Buy $24 → $30
Apr-02-14Reiterated Mizuho Buy $25 → $34
Apr-01-14Reiterated Oppenheimer Outperform $20 → $22
Mar-21-14Initiated Mizuho Buy $25
Mar-14-14Reiterated Stifel Buy $17 → $19
Jan-27-14Reiterated Maxim Group Buy $16 → $25
Oct-17-13Reiterated Ladenburg Thalmann Buy $15 → $19
Aug-01-13Reiterated Maxim Group Buy $9 → $12
Jan-29-13Reiterated Stifel Nicolaus Buy $4 → $13
Jan-29-13Reiterated MLV & Co Buy $5 → $15
Jan-29-13Reiterated Ladenburg Thalmann Buy $5 → $15
Jan-29-13Reiterated Burrill Institutional Research Mkt Outperform $6 → $11
Dec-17-14 08:30AM  TG Therapeutics, Inc. Announces Appointment of Kenneth Hoberman to Board of Directors GlobeNewswire
Dec-11-14 05:02PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Dec-08-14 07:30AM  Keryx Biopharmaceuticals, Inc. to Present at the Oppenheimer & Co. Inc. 25th Annual Healthcare Conference GlobeNewswire
Dec-05-14 12:00PM  Baupost adds to position in Keryx Biopharmaceuticals Market Realist +5.07%
Dec-04-14 07:30AM  Keryx Biopharmaceuticals Announces Issuance of a New U.S. Patent for Auryxia(TM) (ferric citrate) Covering Orally Administrable Forms GlobeNewswire
Dec-02-14 07:30AM  Auryxia(TM) (Ferric Citrate) Phase 2 Data Published in the American Journal of Kidney Disease GlobeNewswire
Dec-01-14 10:00AM  Keryx Biopharmaceuticals (KERX) Highlighted As Weak On High Volume at TheStreet
Nov-18-14 01:17PM  Mid-Day Market Update: SunEdison, TerraForm Jump On First Wind Acquisition; TJX Shares Drop Benzinga
06:03AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Nov-17-14 05:15PM  Keryx Biopharmaceuticals Announces Trade Name Auryxia(TM) for Ferric Citrate GlobeNewswire
04:56PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Nov-15-14 10:00AM  Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase 3 Long-Term Safety Extension Study GlobeNewswire
Nov-14-14 06:08PM  Baupost's Seth Klarman Buys Cheniere Energy, Ocwen Financial, Antero Resources, Sells Boyd ... Gurufocus
01:04PM  KERYX BIOPHARMACEUTICALS INC Financials EDGAR Online Financials
08:30AM  Keryx Biopharmaceuticals, Inc. to Present at the Stifel 2014 Healthcare Conference GlobeNewswire
Nov-12-14 12:33PM  A quarterback's market playbook CNBC
Nov-10-14 07:09PM  Lighting Round: This one is a strong buy at CNBC
07:07PM  Cramer Remix: Stocks with years of upside at CNBC
Nov-08-14 07:07PM  10-Q for Keryx Biopharmaceuticals, Inc. Company Spotlight
Nov-07-14 09:52AM  Keryx Biopharmaceuticals (KERX) Highlighted As Today's Perilous Reversal Stock at TheStreet
06:24AM  Keryx (KERX) in Focus: Stock Adds 11.9% in Session Zacks
Nov-06-14 08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today CCBN +11.91%
07:36AM  Keryx Biopharma misses Street 3Q forecasts AP
07:31AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
07:07AM  Q3 2014 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open CCBN
07:00AM  Keryx Biopharmaceuticals, Inc. Announces Third Quarter and Nine Month 2014 Financial Results GlobeNewswire
Nov-04-14 03:35PM  Will Keryx Biopharmaceuticals (KERX) Post Wider Q3 Loss? Zacks
Oct-30-14 08:00AM  Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2014 Financial Results GlobeNewswire
Oct-28-14 01:12PM  Big Board Biotech Stocks in Play This Week Accesswire
Oct-23-14 10:52AM  Keryx Biopharmaceuticals Announces Ferric Citrate Presentations at the Upcoming American Society of Nephrology Kidney Week 2014 Annual Meeting GlobeNewswire
Oct-10-14 07:00AM  Biotech Stock Mailbag: Keryx, Puma, Gilead, Arrowhead and Hate Mail Galore! at TheStreet -5.31%
Oct-08-14 10:22AM  Insider Trading Alert - VNTV, ENTG And KERX Traded By Insiders at TheStreet +5.17%
Oct-01-14 07:30AM  Keryx Biopharmaceuticals Announces Issuance of a New U.S. Patent for Ferric Citrate Covering Orally Administrable Forms GlobeNewswire
Sep-29-14 07:30AM  Keryx Biopharmaceuticals Initiates Pivotal Phase 3 Study of Ferric Citrate for the Treatment of Iron Deficiency Anemia in Patients With Non-Dialysis Dependent Chronic Kidney Disease GlobeNewswire
Sep-11-14 10:30AM  Insider Trading Alert - DVA, DATA And KERX Traded By Insiders at TheStreet
07:59AM  The Zacks Analyst Blog Highlights: AbbVie, Infinity Pharmaceuticals, Keryx Biopharmaceuticals, Gilead and Amgen Zacks
Sep-08-14 05:05PM  Keryx Falls after Ferric Citrate's Approval with Warnings Zacks -11.17%
04:09PM  Keryx CEO says FDA warning label for drug is 'grossly misunderstood' at MarketWatch
01:11PM  [$$] Keryx's FDA Approval a Mixed Bag at Barrons.com
11:25AM  Why Keryx Biopharmaceuticals (KERX) Stock Is Falling Today at TheStreet
07:09AM  Keryx Biopharmaceuticals (KERX) Crumbles: Stock Falls by 5.5% Zacks
07:00AM  Keryx Bear Case Bolstered by Less-Than-Zippy 'Zerenex' Label at TheStreet
06:20AM  Keryx Biopharma downgraded by FBR Capital Briefing.com
Sep-06-14 09:01AM  Correction: Keryx-Drug Approval story AP
Sep-05-14 08:59PM  Warnings Issued for Keryx Dialysis Drug at New York Times -5.45%
05:08PM  FDA approves Keryx's kidney drug with warnings, shares fall Reuters
05:03PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:00PM  Keryx Biopharmaceuticals, Inc. to Present at the Rodman & Renshaw 16th Annual Global Investment Conference GlobeNewswire
03:05PM  Keryx Finds Out That Not All FDA Approvals Are Great Wins at 24/7 Wall St.
02:49PM  Infoblox Inc. (BLOX) Climbs On Earnings at TheStreet
12:36PM  Infoblox Inc Gains On Upbeat Results; The Gap Inc. Shares Decline Benzinga
12:00PM  Keryx Biopharmaceuticals Inc Conference Call to discuss the approval of Ferric Citrate scheduled for 12:00 pm ET today CCBN
11:28AM  Keryx Biopharma gets U.S. approval for kidney drug Reuters
11:17AM  Keryx Biopharmaceuticals Receives FDA Approval of Ferric Citrate, a New, Oral Iron-Based Treatment for Dialysis Patients With Hyperphosphatemia GlobeNewswire
Aug-26-14 09:50AM  Your September Biotech Back-to-School Calendar at TheStreet
06:39AM  Keryx Biopharmaceuticals (KERX) in Focus: Stock Adds 8.4% in Session Zacks
Aug-25-14 01:32PM  Barbarian At The Gate: Keryx Biopharmaceuticals (KERX) at TheStreet +8.43%
Aug-14-14 07:02PM  Seth Klarman's The Baupost Group Buys eBay, SunEdison Semiconductor, Keryx Biopharmaceuticals, ... Gurufocus
Aug-08-14 09:24AM  H.C. Wainwright & Co. Believes Keryx Biopharmaceuticals Remains Undervalued Benzinga
Aug-07-14 08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today CCBN
07:50AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
07:07AM  Q2 2014 Keryx Biopharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
07:00AM  Keryx Biopharmaceuticals, Inc. Announces Second Quarter and Six Month 2014 Financial Results GlobeNewswire
Aug-05-14 08:00AM  Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2014 Financial Results GlobeNewswire
Jul-24-14 05:00PM  Keryx drug improves phosphorus, iron in kidney patients -trial Reuters
05:00PM  Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology GlobeNewswire
Jul-22-14 08:46AM  Should You Join This Major Hedge Fund in Buying Keryx Stock? at Motley Fool
Jun-24-14 05:01PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
08:00AM  Keryx Biopharmaceuticals: Baupost Group's New Position Suggests A Possible Takeout And 100%+ Gains at Seeking Alpha
Jun-18-14 08:30AM  Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate GlobeNewswire
Jun-17-14 04:30PM  Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference GlobeNewswire
Jun-06-14 06:02PM  4 Reasons Why Wall Street Hates Keryx Biopharmaceuticals Inc. at Motley Fool
09:00AM  The Baupost Group buys a new position in Keryx Biopharmaceuticals Market Realist
Jun-05-14 12:33PM  Must-know highlights of the Baupost Groups 1Q 2014 positions Market Realist
08:30AM  Keryx Biopharmaceuticals, Inc. to Present at the 35th Annual Goldman Sachs Global Healthcare Conference GlobeNewswire
May-29-14 07:34PM  Keryx Biopharma: Approval Delay Does Not Change Zerenex Prospects Or Differentiation at Seeking Alpha
May-23-14 11:00AM  Options with decreasing implied volatility at theflyonthewall.com
08:48AM  Today's Top Health Care Stocks to Watch: PTC Therapeutics, Inovio Pharmaceuticals and Keryx Biopharmaceuticals at Motley Fool
07:30AM  Keryx PDUFA extension creates buying opportunity, says Oppenheimer at theflyonthewall.com
May-22-14 05:21PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:33PM  Keryx announces FDA extends PDUFA date for Zerenex at theflyonthewall.com
04:30PM  Keryx Receives Notification of PDUFA Date Extension for Zerenex(TM) GlobeNewswire
May-19-14 05:35PM  Biotech Tweet of the Week: Investing in Moldy Pizza at Motley Fool
11:40AM  Seth Klarman's Baupost: Investment Changes During The First Quarter at Seeking Alpha
11:20AM  Deerfield reports 4.87% passive stake in Keryx at theflyonthewall.com
May-12-14 06:43PM  Baupost's Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals Gurufocus +5.20%
09:22AM  2014 FDA Drug Approval Calendar at TheStreet
08:12AM  UPDATE: MLV & Co Reiterates On Keryx Biopharmaceuticals On Increased Risk Benzinga
May-09-14 04:03PM  The Baupost Group reports 10.07% passive stake in Keryx at theflyonthewall.com
May-08-14 03:42PM  Why Keryx Biopharmaceuticals (KERX) Stock Is Down Today at TheStreet -13.72%
02:31PM  Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
01:10PM  Why Keryx Biopharmaceuticals, Inc. Shares Swooned at Motley Fool
12:16PM  Keryx weakness a buying opportunity, says Brean Capital at theflyonthewall.com
11:31AM  Keryx June volatility elevated into PDUFA at theflyonthewall.com
08:00AM  Keryx Biopharmaceuticals, Inc. Earnings Call scheduled for 8:00 am ET today CCBN
07:22AM  Keryx reports Q1 EPS (15c), consensus (8c) at theflyonthewall.com
07:18AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
07:07AM  Q1 2014 Keryx Biopharmaceuticals, Inc. Earnings Release - Time Not Supplied CCBN
07:00AM  Keryx Biopharmaceuticals, Inc. Announces First Quarter 2014 Financial Results GlobeNewswire
May-06-14 08:00AM  Keryx Biopharmaceuticals Announces Opening of Boston Office GlobeNewswire
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. It is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company has completed Phase III clinical program for Zerenex for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with chronic kidney disease on dialysis. Zerenex has also completed a Phase II study for the management of elevated serum phosphorus levels and iron deficiency anemia in patients with stages three to five non-dialysis dependent chronic kidney disease. The company has sublicense agreements with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Zerenex in Japan. It also has strategic alliances with Panion & BF Biotech, Inc. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Oliviero James F IIIChief Financial OfficerDec 10Option Exercise11.2225,000280,500178,345Dec 12 08:01 PM
Oliviero James F IIIChief Financial OfficerDec 10Sale15.6925,000392,250153,345Dec 12 08:01 PM
BENTSUR RONChief Executive OfficerOct 06Sale15.8768,8001,091,856755,977Oct 07 08:00 PM
Oliviero James F IIIChief Financial OfficerOct 03Sale16.142,69443,481153,345Oct 07 08:00 PM
BENTSUR RONChief Executive OfficerOct 03Sale16.142,03832,893824,777Oct 07 08:00 PM
BENTSUR RONChief Executive OfficerSep 12Sale14.2450,000712,000826,815Sep 12 08:30 PM
Oliviero James F IIIChief Financial OfficerSep 08Sale15.88144,2372,290,484156,039Sep 10 08:00 PM
BENTSUR RONChief Executive OfficerJul 07Sale15.751,78828,161876,815Jul 09 08:00 PM
Oliviero James F IIIChief Financial OfficerJul 07Sale15.752,05432,351300,276Jul 09 08:00 PM
Oliviero James F IIIChief Financial OfficerApr 03Sale16.462,08734,352302,330Apr 07 07:24 PM
BENTSUR RONChief Executive OfficerApr 03Sale16.461,81629,891878,603Apr 07 07:18 PM
Oliviero James F IIIChief Financial OfficerMar 21Sale15.1113,444203,139304,417Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerMar 20Sale15.04125,0001,880,000317,861Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerMar 19Option Exercise3.54104,039367,812596,900Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerMar 19Sale15.23154,0392,346,014442,861Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerJan 03Sale12.576,30979,304492,861Jan 06 08:00 PM
BENTSUR RONChief Executive OfficerJan 03Sale12.575,25766,080880,419Jan 06 08:00 PM
Oliviero James F IIIChief Financial OfficerDec 30Option Exercise4.5930,000137,700506,429Dec 31 08:00 PM
Oliviero James F IIIChief Financial OfficerDec 30Sale12.6379,5001,003,890476,429Dec 31 08:00 PM
Oliviero James F IIIChief Financial OfficerDec 27Sale12.6830,000380,400525,929Dec 31 08:00 PM